Medications
Advanced ovarian cancer treatment approved
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
Oct 14, 2019
0
2
Ovarian Cancer
Oncology & Cancer
New treatment combination could work against broader array of cancer cells, study finds
In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine (UMSOM) have identified a new pathway that leads to the destruction of cancer cells. The new finding, ...
Oct 15, 2019
0
83
Health
J&J recalls baby powder after trace asbestos found in bottle
Johnson & Johnson on Friday recalled a single batch of its baby powder as a precaution after government testing found trace amounts of asbestos in one bottle bought online.
Oct 18, 2019
0
4
Health
J&J recalls baby powder after trace asbestos found in bottle
Johnson & Johnson is recalling a single lot of its baby powder as a precaution after government testing found trace amounts of asbestos in one bottle bought online.
Oct 18, 2019
0
0
Oncology & Cancer
New class of drugs could stop cancers developing treatment resistance
Scientists at Massey University in New Zealand have taken the first step towards a new class of drug that could stop cancer from becoming resistant to treatment. Treatment resistance is a serious problem to the successful ...
Oct 15, 2019
0
3
Genetics
Researchers quantify limitations of health reports from direct-to-consumer genetic tests
Health reports from direct-to-consumer (DTC) genetic tests that use a limited variant screening approach often yield clinical false-negative results, which pose the risk of informing health care decisions based on incomplete ...
Oct 17, 2019
0
3
Oncology & Cancer
PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free ...
Sep 28, 2019
0
4
Oncology & Cancer
Breast and ovarian cancer drug outperforms targeted hormone therapy in some men
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings ...
Sep 30, 2019
0
1
Oncology & Cancer
Ovarian cancer: more women benefit from maintenance combined targeted therapy
New data presented at the ESMO Congress 2019 in Barcelona, Spain, show the benefit of a more intensive maintenance regimen for ovarian cancer with the PARP inhibitor olaparib added to bevacizumab, in an all-comers population, ...
Sep 28, 2019
0
5
Oncology & Cancer
PTSD symptoms tied to higher risk for ovarian cancer
(HealthDay)—Posttraumatic stress disorder (PTSD) symptoms are associated with an increased risk for ovarian cancer, especially among premenopausal women, according to a study published online Sept. 5 in Cancer Research.
Oct 03, 2019
0
6
Oncology & Cancer
New treatment improves survival in women newly diagnosed with advanced ovarian cancer
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their ...
Sep 28, 2019
0
5
Oncology & Cancer
More accurate diagnosis for rare ovarian cancer type
UNSW medical researchers have shown how a biomarker could help doctors more accurately diagnose one of the rarest types of ovarian cancer.
Oct 03, 2019
0
18
Oncology & Cancer
'Wild idea' opens possible new frontier for preventing ovarian cancer
A laboratory study published in Clinical Cancer Research offers a new hypothesis about how ovarian cancer forms and suggests how it might be prevented.
Oct 09, 2019
0
44
Medications
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer's key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Oct 04, 2019
0
7
Medications
Targeted therapy slows progression of advanced prostate cancer
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and potentially improve survival, paving the way for a new approach to treatment of the most common form of cancer ...
Sep 30, 2019
0
4
Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating and frequent urination, and are easily confused with other illnesses.
Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from the surface (epithelium) of the ovary. However, some evidence suggests that the fallopian tube could also be the source of some ovarian cancers. Since the ovaries and tubes are closely related to each other, it is thought that these fallopian cancer cells can mimic ovarian cancer. Other types may arise from the egg cells (germ cell tumor) or supporting cells. These cancers are grouped into the category of gynecologic cancer.
This text uses material from Wikipedia licensed under CC BY-SA
